Prolymphocytic Leukemia: Malignancy of Activated B Cells with an Apoptosis-like Response to Anti-Human IgM Signal Transduction

References

• Catovsky D., Galetto J., Okos A., Galton D. A. G., Wiltshaw E., Stathopoulos G. Prolymphocytic leukemia of B and T cell type. Lancet 1973; ii: 232–4
   Google Scholar
• Galton D. A. G., Goldman J. M., Wiltshaw E., Catovsky D., Henry K., Goldenberg G. J. Prolymphocytic Leukaemia. Brit. J. Haematol 1974; 27: 7–23
   PubMed Web of Science ®Google Scholar
• Dighiero G., Bodega E., Mayzner R., Binet J. L. Individual cell-by-cell quantitation of lymphocyte surface membrane Ig in normal and CLL lymphocytes and during ontogeny of mouse B lymphocytes by immunoperoxidase assay. Blood 1980; 55: 93–100
   PubMed Web of Science ®Google Scholar
• Catovsky D., Wechsler A., Cherchi M. M-rosettes in B-cell leukemias. Blood 1981; 58: 410–1
   PubMedGoogle Scholar
• Catovsky D., Cherchi M., Brooks D., Bradley J., Zola H. Heterogeneity of B-cell leukemias demonstrated by the monoclonal antibody FMC7. Blood 1981; 58: 406–8
   PubMed Web of Science ®Google Scholar
• Melo J. V., Catovsky D., Galton D. A. G. The relationship between chronic lymphocytic leukaemia: I. Clinical and laboratory features of 300 palients and characterization of an intermediate group. Brit. J. Haematol 1986; 63: 377–87
   PubMed Web of Science ®Google Scholar
• Enno A., Catovsky D., O'Brien M., Cherchi M., Kumaran T. O., Gallon D. A. G. Prolymphocytoid transformation of chronic lymphocytic fluctuations. Brit. J. Haematol 1979; 41: 9–18
   PubMed Web of Science ®Google Scholar
• Muraguchi A., Butler J. L, Kehrl J. H., Fauci A. S. Differential sensitivity of human B cell subsets to activation signals delivered by anti-μ antibody and proliferative signals delivered by a monoclonal B cell growth factor. J. Exp. Med 1983; 157: 530–546
   PubMed Web of Science ®Google Scholar
• Metcalf E. S., Klinman N. R. In vitro tolerance of bone marrow cells: a marker for B cell maturation. J. Immunol 1977; 118: 2111–6
   PubMed Web of Science ®Google Scholar
• Maruyama S. H., Kubagawa H., Cooper M. D. Activation of human B cells, and inhibition of their terminal differentiation by monoclonal anti-μ antibodies. J. Immunol 1985; 135: 192–9
   PubMed Web of Science ®Google Scholar
• Raff M. C., Owen J. T., Cooper M. D., Lawton A. R., Megson M., Gathings W. E. Differences in susceptibility of mature and immature mouse B lymphocytes to antiimmunoglobulin-induced immunoglobulin suppression in vitro. J. Exp. Med 1975; 142: 1052–64
   PubMed Web of Science ®Google Scholar
• DeFranco A. L., Gold M. R, Jakway J. P. B lymphocyte signal transduction in response to anti-immunoglobulin and bacterial lipopolysaccharide. Immunol. Rev 1987; 95: 161–76
   PubMed Web of Science ®Google Scholar
• Scott D. W. Mechanism in immune tolerance. CRC. Crit. Rev. Immunol 1984; 5: 1–25
   Google Scholar
• Boyd A. W., Schrader J. W. The regulation of growth and differentiation of a murine B cell lymphoma: II. The inhibition of WEHI-231 by anti-immunoglobulin antibodies. J. Immunol 1981; 126: 2466–9
   PubMed Web of Science ®Google Scholar
• Pennell C. A., Scott D. W. Lymphoma models for B cell activation and tolerance: IV. Growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells. Eur. J. Immunol 1986; 16: 1577–81
   PubMed Web of Science ®Google Scholar
• Jakway J. P., Usinger W. R., Gold M. R., Mishell R. I., DeFranco A. L. Growth regulation of the B cell lymphoma cell line WEHI-231 by anti-immunoglobulin, lipopolysaccharide, and other bacterial products. J. Immunol 1986; 137: 2225–31
   PubMed Web of Science ®Google Scholar
• Severison E., Torres A., Moller G. Activation of BCL1 cells by polyclonal activators and inhibition of growth and IgM secretion by anti-IgM. Scand. J. Immunol 1983; 18: 153–62
   PubMed Web of Science ®Google Scholar
• Ralph P., Nakoinz I. Lipopolysaccharides inhibit lymphosarcoma cells of bone marrow origin. Nature 1974; 249: 49–51
   PubMed Web of Science ®Google Scholar
• Gordon J., Melamed M. D., Ley S. C., Hughes-Jones N. C. Anti-immunoglobulin inhibits DNA synthesis in Epstein-Barr virus-transformed lymphoblastoid cell lines. Immunol 1984; 52: 79–85
   PubMed Web of Science ®Google Scholar
• Mongini P., Blessinger C., Seremetis S., Winchester R., Rudich S. Human leukemic B cell activation: functional consequence of membrane IgM interaction with anti-IgM ligand is an alterable cell characteristic. Blood 1987; 70: 1193–1202
   PubMed Web of Science ®Google Scholar
• Baeker T. R., Rothstein T. L. Effects of anti-IgM on mitogen-induced proliferation of human B-lymphocyte malignancies. Clin. Immunol. Immunopathol 1986; 39: 285–97
   PubMedGoogle Scholar
• DeFranco A. L., Davis M. M., Paul W. E. WEHI-231 as a tumor model for tolerance induction in immature B lymphocytes, B T. Tumors, E.S. Vitetta. Academic Press, New York 1982; 445–8
   Google Scholar
• Sidman C. L., Unanue E. R. Control of B lymphocyte function. I. Inactivation of mitogenesis by interactions with surface immunoglobulin and Fc-receptor molecules. J. Exp. Med 1976; 144: 882–96
   PubMed Web of Science ®Google Scholar
• Kearney J. F., Klein J., Bockman D. E., Cooper M. D., Lawton A. R. B cell differentiation induced by lipopolysaccharides V. Suppression of plasma cell maturation by anti-μ: mode of action and characteristics of suppressor cells. J. Immunol 1978; 120: 158–66
   PubMed Web of Science ®Google Scholar
• Chan C. S. P., Soehnlen F., Schechter G. P. Differential response of malignant human B-cells to anti-IgM immunoglobulin (anti-μ) and B-cell growth factor: unique direct cytotoxicity of anti-μ on prolymphocytic leukemia cells. Blood 1990; 76: 1601–6
   PubMed Web of Science ®Google Scholar
• Kawano M., Iwato K., Asaoku H., Tanabe O., Tanaka H., Ishikawa H., Imamura N., Kuramoto A. Heterogeneous response of B cell chronic lymphocytic leukaemia (B-CLL) cells to anti-human IgM antibody (anti-μ) and B cell stimulatory factor 1 (BSF-1). Brit. J. Haematol 1989; 71: 47–51
   PubMed Web of Science ®Google Scholar
• Smith C. A., William G. T., Kingston R., Jenkinson E. J., Owen J. J. T. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 1989; 337: 181–4
   PubMed Web of Science ®Google Scholar
• Odaka C., Kizaki H., Tadakuma T. T cell receptor-mediated DNA fragmentation and cell death in T cell hybridomas. J. Immunol 1990; 144: 2097–101
   Google Scholar
• Trauth B. C., Klas C., Peters A. M. J., Matzku S., Moller P., Falk W., Debatin K. M., Krammer P. H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245: 301–5
   PubMed Web of Science ®Google Scholar
• Hockenbery D., Nunez G., Milliman C., Schreiber R. D., Korsmeyer S. J. Bcl-2 expression is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334–6
   PubMed Web of Science ®Google Scholar
• Zutter M. M., Hockenbery D., Silverman G. A., Korsmeyer S. J. Bcl-2 expression in a large panel of hematopoietic malignancies. Blood 1990; 379a
   Google Scholar
• Durie B. G. M., Mason D. Y., Giles F., Vela E. E., Knight I., Wolff S., Foadi M., Samson D. Expression of the bcl-2 oncogene protein in multiple myeloma. Blood 1990; 347a
   Google Scholar
• Rudich S. M., Roux K. H., Winchester R. J., Mongini P. K. A. Anti-IgM-mediated B cell signaling: molecular analysis of ligand binding requisites for human B cell clonal expansion and tolerance. J. Exp. Med 1988; 168: 247–66
   PubMed Web of Science ®Google Scholar
• Hivroz C., Grillof-Courvatin C., Brouet T. C., Seligmann M. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin-2. Eur. J. Immunol 1986; 16: 1001–4
   PubMed Web of Science ®Google Scholar
• Perri R. T. Impaired expression of cell surface receptors for B cell growth factor by chronic lymphocytic leukemia B cells. Blood 1986; 67: 943–8
   PubMed Web of Science ®Google Scholar
• Robert K. H., Juliusson G., Biberfeld P. Chronic lymphocytic leukaemia cells activated in vitro reveal cellular changes that characterize B-prolymphocytic leukaemia and immunocytoma. Scand. J. Immunol 1983; 17: 397–401
   PubMed Web of Science ®Google Scholar
• Melo J. V., Catovsky D., Galton D. A. G. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia: II. Pattern of evolution of “prolymphocytoid” transformation. Brit. J. Hematol 1986; 64: 77–86
   PubMed Web of Science ®Google Scholar
• Berrebi A., Bassous-Guedj L., Vorst E., Dagan S., Shtalrid M., Freedman A. Further characterization of prolymphocytic leukemia cells as a tumor of activated B cells. Am. J. Hematol 1990; 34: 181–5
   PubMed Web of Science ®Google Scholar
• Miller R. A., Maloney D. G., Warnke R., Levy R. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N. Engl. J. Med 1982; 306: 517–22
   PubMed Web of Science ®Google Scholar
• Meeker T. C., Lowder J., Maloney D. G., Miller R. A., Thielemans K., Warnke R., Levy R. A clinical trial of anti-idiotype therapy for B cell malignancy. Blood 1985; 65: 1349–63
   PubMed Web of Science ®Google Scholar
• Lowder J. N., Meeker T. C., Campbell M., Garcia C. F., Gralow J., Miller R. A., Warnke R., Levy R. Studies of B lymphoid tumors treated with monoclonal anti-idiotype antibodies: correlation with clinical responses. Blood 1987; 69: 199–210
   PubMed Web of Science ®Google Scholar
• Horning S. J., Rosenberg S. A. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N. Engl. J. Med 1984; 311: 1471–5
   PubMed Web of Science ®Google Scholar
• Ashwell J. D., Longo D. L., Bridges S. H. T-cell tumor elimination as a result of T-cell receptor-mediated activation. Science 1987; 237: 61–4
   PubMed Web of Science ®Google Scholar
• Ashwell J. D., Cunningham R. E., Noguchi P. D., Hernandez D. Cell growth cycle block of T cell hybridomas upon activation with antigen. J. Exp. Med 1987; 165: 173–94
   PubMed Web of Science ®Google Scholar
• Ucker D. S., Ashwell J. D., Nickas G. Activation-driven T cell death: I. Requirements for de novo transcription and translation and association with genome fragmentation. J. Immunol 1989; 143: 3461–9
   PubMed Web of Science ®Google Scholar